Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression profiles of cell populations purified from human CRC (3 ways)


ABSTRACT: The survival of isolated metastatic cells and expansion into macroscopic tumour has been recognized as a limiting step for metastasis formation in several cancer types yet the determinants of this process remain largely uncharacterized. In colorectal cancer (CRC), we identify a transcriptional programme in tumour-associated stromal cells, which is intimately linked to a high risk of developing recurrent disease after therapy. A large proportion of CRCs display mutational inactivation of the TGF-beta pathway but paradoxically they are characterized by high TGF-beta production. In these tumours, TGF-beta instructs a transcriptional programme in stromal cells, which confers a high risk of developing metastatic disease. We purified by FACS [CD45(+),Epcam(-)], [CD45(-) Epcam(+)] and [CD45(-) Epcam(-)] cell populations from fresh CRC samples and assessed their gene expression profiles Freshly obtained tumors from CRC patients (n=8) treated at Hospital del Mar (Barcelona, Spain) were minced and incubated with 0.1% Hyaluronidase and 0.1% Collagenase 1A. Pieces were then homogenized. Enzymatic reaction was stopped by adding 10% FBS and single cells were collected by sequential filtering. Cells were resuspended in Ammonium Chloride (0.15M) to lyse erythrocytes. Cells were stained with anti-hEpcam/TROP1-APC and anti-CD45-PE conjugated antibody. Dead cells were labeled with Propidium Iodide. Fluorescence Activated Cell Sorting (FACS) was used to separate cells.

ORGANISM(S): Homo sapiens

SUBMITTER: Alexandre CALON 

PROVIDER: E-GEOD-39395 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


A large proportion of colorectal cancers (CRCs) display mutational inactivation of the TGF-β pathway, yet, paradoxically, they are characterized by elevated TGF-β production. Here, we unveil a prometastatic program induced by TGF-β in the microenvironment that associates with a high risk of CRC relapse upon treatment. The activity of TGF-β on stromal cells increases the efficiency of organ colonization by CRC cells, whereas mice treated with a pharmacological inhibitor of TGFBR1 are resilient to  ...[more]

Similar Datasets

2013-01-17 | GSE39395 | GEO
2013-01-17 | E-GEOD-39396 | biostudies-arrayexpress
2013-01-17 | GSE39396 | GEO
2013-01-17 | E-GEOD-39394 | biostudies-arrayexpress
2013-01-17 | GSE39394 | GEO
2018-02-12 | GSE103562 | GEO
2021-12-10 | GSE173565 | GEO
2015-05-11 | E-GEOD-57391 | biostudies-arrayexpress
| PRJNA813160 | ENA
2015-05-11 | GSE57391 | GEO